Results 101 to 110 of about 38,466 (239)
Рациональная фармакотерапия в кардиологии, 2015 Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods.
L. A. Bondarenko +4 more
doaj +1 more source
Prevalence and Risk Factors for Cerebral Microbleeds in Chinese Patients With Acute Ischemic Stroke
Brain and Behavior, Volume 16, Issue 6, June 2026.Approximately half of the patients with AIS exhibited CMBs, particularly those classified under LAA and SVD subtypes. Hypertension and severe WMH were independently associated with CMB presence. Distinct clinical profiles were observed based on CMB burden and location.
Ruiming Zhu +5 more
wiley +1 more source
Are All Intracranial Mass Lesions Always a Contraindication for Thrombolytic Therapy?
, 2014 Thrombolytic therapy is regarded as the first treatment choice in haemodynamically unstable patients with pulmonary embolism. Intracranial tumors have long been considered as a contraindication to thrombolytic therapy due to the risk of intracerebral ...
Gullupinar, B. +5 more
core +1 more source
ETV4 Improves Cerebral Ischemia‐Reperfusion Injury by Restraining YBX1‐GPX4‐Ferroptosis Cascades
Brain and Behavior, Volume 16, Issue 6, June 2026.ABSTRACT Background Cerebral ischemia‐reperfusion injury (CIRI) is a critical pathological process following ischemic stroke, with ferroptosis being increasingly recognized as a key contributor to neuronal damage. However, the regulatory mechanisms, particularly the role of specific transcription factors like E26 transformation‐specific variant 4 (ETV4)
Qian Xu, Faming Deng, Dan Yu
wiley +1 more source
A Comparison of Thrombolytic Therapy and Primary Angioplasty in Patients with Acute Myocardial Infarction [PDF]
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i BābulBackground and Objective: The standard treatment for patients with acute myocardial infarction is to reestablish blood flow in the blocked vessels, which is possible through angioplasty and thrombolytic therapy. However, even in developed countries, some
MS Ramezani +5 more
doaj
CNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.Post‐stroke administration of TSN significantly reduced infarct volume, neuroinflammation, and improved functional recovery of MCAO mice. TSN alleviated neural oxidative stress, lipid peroxidation, and ferroptosis in MCAO mice. TSN modulated the infiltration of immune cells in MCAO mice in vivo and T cell differentiation in vitro.
Xinyun Li +5 more
wiley +1 more source
Local and systemic thrombolytic therapy for acute deep venous thrombosis. [PDF]
, 2005 Contains fulltext : 48677.pdf (Publisher’s version ) (Open Access)This article presents a review of the treatment of lower-extremity deep venous thrombosis (DVT) with systemic and catheter-directed thrombolysis (CDT) and percutaneous ...
Janssen, M.C.H. +3 more
core
, 2002 BACKGROUND: Post-myocardial infarction ventricular septal defect (VSD) complicates approximately 2% of myocardial infarctions. Thrombolytic therapy may accelerate the time from myocardial infarction to VSD formation.
Schofield, PM +5 more
core +1 more source
پزشکی بالینی ابن سینا, 2005 Acute myocardial infarction (AMI ) is one of the most common cause of mortality in almost all countries of the world. According to this fact that thrombus formation and coronary obstruction are the basic pathophysiology of AMI , early thrombolysis and
Shahram Homayonfar +2 more
doaj
Nanoparticles in Vascular Dementia: Advantages and Challenges
CNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.This review highlights the dual diagnostic and therapeutic potential of nanomaterials in Vascular Dementia (VaD). By effectively crossing the blood–brain barrier, functionalized nanoparticles facilitate early diagnosis by targeting Aβ deposits and vascular lesions.
Xianxin Liu +8 more
wiley +1 more source